| Application no. and date | 10182610.5 (espacenet) (Federated) (European Patent Register), 20030815 | | Patent/reg. no. and date | DK/EP 2359856, 20170510 | | Publication date | 20110824 | | Priority no. and date | US 222140, 20020816 | | EP pub. no. and date |
EP 2359856 20110824 | | Effective date | | | Applicant/owner | AbbVie Biotechnology Ltd., Clarendon House
2, Church Street
HM 11 Hamilton, BM | | Applicant ref. no. | P81701641DK00E | | Inventor | DICKES, Michael, Schafergasse 58
67127 Rodersheim-Gronau, DE,
KRAUSE, Hans-Juergen, St. Killian-Strasse 14
67269 Gruenstadt, DE,
Baust, Lisa,
Goethetr. 15a
67063 Ludwigshafen, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/26 (2006.01) , A61K 9/19 (2006.01) | | Title | Formulation of human antibodies for treating TNF-alpha associated disorders | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
